Novartis temporarily suspended the production of the company’s Lutathera and Pluvicto cancer therapies at facilities in Italy and New Jersey after potential quality issues were discovered in their manufacturing.
Ferrero on April 12 asked U.S. consumers to dispose of some Kinder chocolate products not authorized for distribution in the country, warning they could be from the batch recently recalled in Europe due to a potential Salmonella Typhimurium contamination.
Italy on April 1 began to phase out the country’s COVID-19 restrictions, ending a state of emergency public authorities declared more than two years ago that allowed it to bypass bureaucracy and swiftly impose rules via decrees.
Many countries around the world that appeared to have kicked COVID-19 are reporting surges, largely the result of the so-called “stealth” Omicron variant, BA.2.
Immunology is one of the more complicated areas of the life sciences, and recent studies on the long-term efficacy of the mRNA vaccines against Covid-19 are prime examples of just how complicated it can be.
Novartis will manufacture the anti-cholesterol medicine Leqvio at the company’s own plant in Austria to supply the United States as the Swiss drugmaker seeks U.S. approval that has been delayed by regulatory concerns over a contractor’s Italian facility.
The head of the EU drug regulator’s Covid-19 task force said on June 13 that AstraZeneca’s coronavirus vaccine had a favorable risk-benefit profile for all age groups and particularly for those aged over 60.
Americans had the lowest number of babies in more than four decades during 2020, mirroring a slump in European birth rates, as the Covid-19 pandemic forced more people to take care of sick family members or deal with job losses. Birth rate in the United States fell 4 percent in 2020 to about 3.6 million babies, the sixth straight annual decline and the lowest since 1979, according to the U.S. Centers for Disease Control and Prevention.
Fewer Europeans trust the AstraZeneca Covid-19 vaccine after several countries reported side effects, such as blood clots, an opinion poll by YouGov showed on March 22, even though scientific studies have found it is safe and effective.
Russia’s Sputnik V could be produced in western Europe for the first time after a deal to make the Covid-19 vaccine in Italy was signed by the RDIF sovereign wealth fund and Swiss-based pharmaceutical company Adienne.